The presence of pulmonary arterial hypertension (PH) in patients with COPD has been shown to relate to the width of right descending pulmonary artery (rDPA). rDPA> 16 mm is the best discriminant between those patients with and wit-hout PH. The aim of this retrospective study was to investigate the enlargement of rDPA and the factors which affected this parameter in 118 patients with stable COPD. Patients were divided into two groups according to width of rDPA (Gro-up 1: rDPA< 16 mm, Group 2: rDPA ≥ 16 mm). Stepwise discriminant analysis was perfomed to evaluate the most impor-tant factors related with diameter of rDPA. PaO2 and hematocrit (Hct) were the most relevant factors for the discrimination of the two groups. There was statical...
Pulmonary artery enlargement (PAE) is associated with exacerbations in Chronic Obstructive Pulmonary...
International audienceRationale Severe pulmonary hypertension (PH) is very uncommon in COPD, and a d...
Background: Currently, patients with COPD who are evaluated for bronchoscopic treatments are routine...
Purpose. This study aims at investigating the predictive value of red blood cell distribution width ...
Background Pulmonary hypertension (PH) is a major predictor of exercise tolerance and mortality in c...
INTRODUCTION: Pulmonary hypertension (PH) in COPD is associated with a higher mortality and an incre...
Chronic obstructive pulmonary disease (COPD) is in up to 90 % of all cases caused by smoking. COPD o...
PurposeIt is postulated that ILD causes PA dilatation independent of the presence of pulmonary hyper...
Xuesong Chen,1,* Kouying Liu,1,* Zhiyue Wang,2 Yinsu Zhu,2 Yang Zhao,3 Hui Kong,1 Weiping Xie,1 Hong...
Aim: To determine the diagnostic accuracy of pulmonary artery to aorta ratio in screening for pulmon...
Introduction Little is known about the relationship between health status and pulmonary artery di...
SummaryRationaleThe relationship between pulmonary artery size with underlying pulmonary hypertensio...
Background: Chronic Obstructive Pulmonary Disease (COPD) is associated with subclinical systemic ath...
WOS: 000209370401276Body: Bacgraund: Chronic obstructive pulmonary disease (COPD) increases the risk...
Rationale: Assessing the function of the right side of the heart along with diagnosing of pulmonary ...
Pulmonary artery enlargement (PAE) is associated with exacerbations in Chronic Obstructive Pulmonary...
International audienceRationale Severe pulmonary hypertension (PH) is very uncommon in COPD, and a d...
Background: Currently, patients with COPD who are evaluated for bronchoscopic treatments are routine...
Purpose. This study aims at investigating the predictive value of red blood cell distribution width ...
Background Pulmonary hypertension (PH) is a major predictor of exercise tolerance and mortality in c...
INTRODUCTION: Pulmonary hypertension (PH) in COPD is associated with a higher mortality and an incre...
Chronic obstructive pulmonary disease (COPD) is in up to 90 % of all cases caused by smoking. COPD o...
PurposeIt is postulated that ILD causes PA dilatation independent of the presence of pulmonary hyper...
Xuesong Chen,1,* Kouying Liu,1,* Zhiyue Wang,2 Yinsu Zhu,2 Yang Zhao,3 Hui Kong,1 Weiping Xie,1 Hong...
Aim: To determine the diagnostic accuracy of pulmonary artery to aorta ratio in screening for pulmon...
Introduction Little is known about the relationship between health status and pulmonary artery di...
SummaryRationaleThe relationship between pulmonary artery size with underlying pulmonary hypertensio...
Background: Chronic Obstructive Pulmonary Disease (COPD) is associated with subclinical systemic ath...
WOS: 000209370401276Body: Bacgraund: Chronic obstructive pulmonary disease (COPD) increases the risk...
Rationale: Assessing the function of the right side of the heart along with diagnosing of pulmonary ...
Pulmonary artery enlargement (PAE) is associated with exacerbations in Chronic Obstructive Pulmonary...
International audienceRationale Severe pulmonary hypertension (PH) is very uncommon in COPD, and a d...
Background: Currently, patients with COPD who are evaluated for bronchoscopic treatments are routine...